223 related articles for article (PubMed ID: 16181625)
1. Cooperative action of 1alpha,25-dihydroxyvitamin D3 and retinoic acid in NB4 acute promyelocytic leukemia cell differentiation is transcriptionally controlled.
Bastie JN; Balitrand N; Guillemot I; Chomienne C; Delva L
Exp Cell Res; 2005 Nov; 310(2):319-30. PubMed ID: 16181625
[TBL] [Abstract][Full Text] [Related]
2. [Effect of translocation t(15;17) on the gene expression regulation of myeloblastin during all trans retinoic acid induced myeloid differentiation in human leukemic cells].
Ballerini P; Besançon F; Cayre YE
C R Seances Soc Biol Fil; 1995; 189(4):521-30. PubMed ID: 8564566
[TBL] [Abstract][Full Text] [Related]
3. Activation of interleukin-1 beta gene expression during retinoic acid-induced granulocytic differentiation of promyeloid leukemia cells.
Matikainen S; Tapiovaara H; Vaheri A; Hurme M
Cell Growth Differ; 1994 Sep; 5(9):975-82. PubMed ID: 7819135
[TBL] [Abstract][Full Text] [Related]
4. All-trans retinoic acid and 1 alpha,25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes.
Brown G; Bunce CM; Rowlands DC; Williams GR
Leukemia; 1994 May; 8(5):806-15. PubMed ID: 8182938
[TBL] [Abstract][Full Text] [Related]
5. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
6. Molecular signature of retinoic acid treatment in acute promyelocytic leukemia.
Meani N; Minardi S; Licciulli S; Gelmetti V; Coco FL; Nervi C; Pelicci PG; Müller H; Alcalay M
Oncogene; 2005 May; 24(20):3358-68. PubMed ID: 15735696
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.
Chomienne C; Balitrand N; Ballerini P; Castaigne S; de Thé H; Degos L
J Clin Invest; 1991 Dec; 88(6):2150-4. PubMed ID: 1661301
[TBL] [Abstract][Full Text] [Related]
8. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
Testa U; Grignani F; Barberi T; Fagioli M; Masciulli R; Ferrucci PF; Seripa D; Camagna A; Alcalay M; Pelicci PG
Cancer Res; 1994 Aug; 54(16):4508-15. PubMed ID: 7519122
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant effects of synthetic retinoids and activated vitamin D3.
Koyama T; Hirosawa S
Semin Thromb Hemost; 1998; 24(3):217-26. PubMed ID: 9701451
[TBL] [Abstract][Full Text] [Related]
10. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
Taimi M; Breitman TR
Biochem Biophys Res Commun; 1997 Mar; 232(2):432-6. PubMed ID: 9125196
[TBL] [Abstract][Full Text] [Related]
11. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression.
Clark CS; Konyer JE; Meckling KA
Exp Cell Res; 2004 Mar; 294(1):301-11. PubMed ID: 14980523
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH
Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820
[TBL] [Abstract][Full Text] [Related]
13. 1 alpha,25-dihydroxyvitamin D3 transrepresses retinoic acid transcriptional activity via vitamin D receptor in myeloid cells.
Bastie JN; Balitrand N; Guidez F; Guillemot I; Larghero J; Calabresse C; Chomienne C; Delva L
Mol Endocrinol; 2004 Nov; 18(11):2685-99. PubMed ID: 15284334
[TBL] [Abstract][Full Text] [Related]
14. A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
Kanatani Y; Makishima M; Ishikawa I; Ogasawara Y; Kawahara N; Motoyoshi K; Nagata N; Honma Y
Exp Hematol; 1998 Mar; 26(3):198-206. PubMed ID: 9502615
[TBL] [Abstract][Full Text] [Related]
15. 1 alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line.
Higashimoto Y; Ohata M; Nishio K; Iwamoto Y; Fujimoto H; Uetani K; Suruda T; Nakamura Y; Funasako M; Saijo N
Anticancer Res; 1996; 16(5A):2653-9. PubMed ID: 8917365
[TBL] [Abstract][Full Text] [Related]
16. Combined vitamin D3/retinoic acid induction of human promyelocytic cell lines: enhanced phagocytic cell maturation and hybrid granulomonocytic phenotype.
Masciulli R; Testa U; Barberi T; Samoggia P; Tritarelli E; Pustorino R; Mastroberardino G; Camagna A; Peschle C
Cell Growth Differ; 1995 May; 6(5):493-503. PubMed ID: 7647032
[TBL] [Abstract][Full Text] [Related]
17. Role of vitamin D3 receptor in the synergistic differentiation of WEHI-3B leukemia cells by vitamin D3 and retinoic acid.
Li J; Finch RA; Sartorelli AC
Exp Cell Res; 1999 Jun; 249(2):279-90. PubMed ID: 10366427
[TBL] [Abstract][Full Text] [Related]
18. Synergistic induction of 1,25-dihydroxyvitamin D(3)- and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps.
Kim SH; Kim TS
Planta Med; 2002 Oct; 68(10):886-90. PubMed ID: 12391550
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by butyric acid, tributyrin, and hexamethylene bisacetamide.
Taimi M; Chen ZX; Breitman TR
Oncol Res; 1998; 10(2):75-84. PubMed ID: 9666515
[TBL] [Abstract][Full Text] [Related]
20. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.
Mann KK; Rephaeli A; Colosimo AL; Diaz Z; Nudelman A; Levovich I; Jing Y; Waxman S; Miller WH
Mol Cancer Res; 2003 Oct; 1(12):903-12. PubMed ID: 14573791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]